Florida SB 886: Discounted Drug Pricing Study

Bill Text

886 
Discounted Drug Pricing Study 
2025-12-12T03:17:47Z 
Requiring the Agency for Health Care Administration to conduct or contract for a specified study; requiring the agency to provide the results to the Governor and the Legislature by a specified date, etc. 
Original Filed Version 
2026 
S 
2026-07-01T00:00:00Z 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 886 

 By Senator Rodriguez 

 40-01022-26 2026886__ 
 1 A bill to be entitled 
 2 An act relating to discounted drug pricing study; 
 3 requiring the Agency for Health Care Administration to 
 4 conduct or contract for a specified study; providing 
 5 requirements for the study; requiring the agency to 
 6 provide the results to the Governor and the 
 7 Legislature by a specified date; providing an 
 8 effective date. 
 9 
 10 Be It Enacted by the Legislature of the State of Florida: 
 11 
 12 Section 1. (1) The Agency for Health Care Administration 
 13 shall conduct or contract for a detailed fiscal impact study to 
 14 determine the feasibility of implementing the following 
 15 provisions relating to discounted drug prices under the 340B 
 16 Drug Pricing Program: 
 17 (a)1. Requiring drug manufacturers to sell a drug to 
 18 Medicaid pharmacies at no more than the 340B Drug Pricing 
 19 Program discounted price if the drug is: 
 20 a. On the Medicaid preferred drug list as described in s. 
 21 409.912(5), Florida Statutes. 
 22 b. A covered drug under the 340B Drug Pricing Program. 
 23 2. Authorizing drug manufacturers to deliver drugs sold in 
 24 accordance with subparagraph 1. to the purchasing Medicaid 
 25 pharmacy by any method used by the drug manufacturer. 
 26 3. If a drug manufacturer sells a drug in accordance with 
 27 subparagraph 1. to a Medicaid pharmacy at the 340B Drug Pricing 
 28 Program discounted price and such discounted price is higher 
 29 than the state Medicaid negotiated price, requiring the drug 
 30 manufacturer to pay a rebate to the state equal to the 
 31 difference between the discounted price and the state Medicaid 
 32 negotiated price. 
 33 (b) Requiring pharmacy benefits managers participating in 
 34 the Medicaid program to pay a Medicaid pharmacy the 340B Drug 
 35 Pricing Program discounted price plus the professional 
 36 dispensing fee as determined under rule 59G-4.251, Florida 
 37 Administrative Code, as amended, for any drug that is on the 
 38 Medicaid preferred drug list as described in s. 409.912(5), 
 39 Florida Statutes, and that is a covered drug under the 340B Drug 
 40 Pricing Program. 
 41 (c)1. Requiring drug wholesalers and distributors to sell a 
 42 drug to a Medicaid pharmacy at the 340B Drug Pricing Program 
 43 discounted price if the drug is: 
 44 a. On the Medicaid preferred drug list as described in s. 
 45 409.912(5), Florida Statutes. 
 46 b. A covered drug under the 340B Drug Pricing Program. 
 47 2. Prohibiting drug wholesalers and distributors from 
 48 changing an existing pricing model or program that is in place 
 49 with a Medicaid pharmacy by exempting a drug described in 
 50 paragraph (a) from the pricing model or program or by 
 51 referencing such drug in any way in the pricing model or 
 52 program. 
 53 (d) Requiring Medicaid pharmacies to provide a covered drug 
 54 under the 340B Drug Pricing Program at the discounted price only 
 55 to Medicaid recipients. 
 56 (2) The agency shall submit the results of the study to the 
 57 Governor, the President of the Senate, and the Speaker of the 
 58 House of Representatives by January 31, 2027. 
 59 Section 2. This act shall take effect July 1, 2026.